VANCOUVER, BC, March 5, 2021 /CNW/ – Slater Vecchio LLP has filed a category motion lawsuit in opposition to Elmiron producers Janssen Prescription drugs and Teva Prescription drugs because of the drug’s hyperlink with imaginative and prescient loss. Elmiron is the one drug available on the market used to deal with Interstitial Cystitis, as there are not any generics or alternate options obtainable. Nevertheless, customers of the drug weren’t warned concerning the potential imaginative and prescient loss aspect impact, regardless that reminiscent of been in scientific literature for a number of years.
Pentosan Polysulphate Sodium (the chemical in Elmiron) construct up has been discovered to be poisonous to the Retinal space, and may trigger Macular Degeneration. Signs related to this are blurred central imaginative and prescient, issue adjusting to gentle, issue evening driving, ache behind the eyes, floaters, and spots. Fortunately, people could be objectively examined to see if their Macular Degeneration is because of their Elmiron use.
Certification for this motion is ready for October 2021, however Slater Vecchio is contacting people affected early. The category for this motion is all people that used Elmiron and have been struggling with imaginative and prescient loss or impairment. If this describes you, arrange an appointment together with your Optometrist or Ophthalmologist to get examined. In case you are a possible Class Member, we encourage you to finish the data kind on the web site of Slater Vecchio LLP at: https://www.slatervecchio.com/elmiron-class-action/
About Slater Vecchio LLP
Slater Vecchio LLP is a boutique legislation agency situated in British Columbia. Over the previous 20 years, Slater Vecchio has represented hundreds of shoppers and has grown into one of many largest private harm and sophistication motion corporations within the province. Slater Vecchio’s purpose is to exceed each shopper’s expectations, not solely with one of the best outcomes attainable, however all through the expertise as we work collectively.
SOURCE Slater Vecchio LLP
For additional info: Media Contacts: Mary Vecchio, Slater Vecchio LLP, [email protected]